Non al co holic fatty liver dis ease (NAFLD) is di agnosed in a sig nifi cant pro por tion of coro nary ar tery dis ease and type 2 dia be tes pa tients, ex ac er bat ing the un der ly ing dis ease. It is fre quently as so ci ated with abdomi nal obesity, dia be tes mel li tus, ar te rial hy per ten sion, age over 45 years and the ra tio of trans ami nase ac tiv ity [10, 6]. Although this dis ease of ten comes across as ymp to matic, the pro gres sion of stea to sis to stea to he pa ti tis is found in almost half of cases and in not less than 1/6 of pa tients fi bro sis of liver de vel ops. It is also known that 72% of patients with coro nary heart dis ease com bined with type 2 dia be tes are di ag nosed with NAFLD [3, 4, 6] The prob lem of the de vel op ment and pro gres sion of NAFLD in ad di tion to coro nary heart dis ease and type 2 dia be tes mel li tus is one of the most im por tant and ur gent tasks of in ter nal medi cine, since it leads to the wors en ing of comor bid dis eases [1]. Pa tients with NAFLD are usu ally as ymp to matic, high val ues of liver en zyme tests be ing the most com mon find
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.